MacroGenics
MGNX
119 hedge funds and large institutions have $638M invested in MacroGenics in 2017 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 42 increasing their positions, 35 reducing their positions, and 14 closing their positions.
57% more call options, than puts
Call options by funds: $1.21M | Put options by funds: $770K
43% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 14
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
20% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 35
9% more capital invested
Capital invested by funds: $583M → $638M (+$55.4M)
5.54% more ownership
Funds ownership: 85.82% → 91.35% (+5.5%)
5% more funds holding
Funds holding: 113 → 119 (+6)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
+$21.3M |
| 2 |
AH
Aviva Holdings
New Providence,
Bahamas
|
+$12.5M |
| 3 |
Millennium Management
New York
|
+$7.75M |
| 4 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
+$7.65M |
| 5 |
O
OppenheimerFunds
New York
|
+$7.18M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$14.3M |
| 2 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$8.23M |
| 3 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$6.62M |
| 4 |
TA
Teachers Advisors
New York
|
-$4.89M |
| 5 |
Jennison Associates
New York
|
-$3.24M |
MGNX Hedge Fund Activity: Q4 2017 in Review
119 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q4 2017, worth a combined $638M — up 9.5% from $583M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new MGNX positions and 14 closed out — a net gain of 6 holders — while 42 added to existing stakes and 35 trimmed.
The largest buyer was EcoR1 Capital, opening a new position worth an estimated $21.3M. The largest seller was Fidelity Investments, cutting an estimated $14.3M.
- 119 institutional investors held MacroGenics (MGNX) as of Q4 2017, up from 113 in Q3 2017.
- Funds reported $638M of MacroGenics stock for Q4 2017, up 9.5% quarter-over-quarter.
- 20 funds opened new MacroGenics positions in Q4 2017 and 14 closed out, a net change of +6 holders.
- The largest MacroGenics buyer in Q4 2017 was EcoR1 Capital, an estimated $21.3M added.
- The largest MacroGenics seller in Q4 2017 was Fidelity Investments, an estimated $14.3M sold.
Based on aggregated 13F filings for Q4 2017.